Tag Archives: antipsychotic

FDA ‘considers’ Antipsychotic drug labels warning of weight gain/diabetes. Considers? Do your job-issue the warnings.

A study published last month in the Journal of the American Medical Association found the drugs caused children and adolescents to gain an average of 19 pounds in 11 weeks of treatment. The concern with weight gain seen with most antipsychotic drugs is whether it causes additional problems such as diabetes and cardiovascular disease. A top Food and Drug Administration official said Tuesday the agency is considering strengthening the labels of antipsychotic drugs to warn about weight gain and diabetes amid concerns the impact could be stronger in children compared to adults.

Pregnant women should stop medications which cause birth defects: “Psychiatric drugs can & should be avoided”

Dr. Anick Berard, at the University of Montreal in Quebec, said medications such as those which treat severe acne, anxiety and psychiatric drugs, antibiotics, and many drugs prescribed for heart disease and medical conditions “can and should be avoided” by women who are pregnant.

Drugmaker pays psychiatrist nearly $500,000 to promote antipsychotic drug Seroquel despite misgivings about his research

AstraZeneca paid Chicago psychiatrist Dr. Michael Reinstein $490,000 over a decade to travel the nation promoting its best-selling antipsychotic drug, Seroquel. In return, Reinstein provided the company a vast customer base: thousands of residents in Chicago-area nursing homes.

Children on antipsychotics 3 times more likely to develop diabetes (a known side effect of antipsychotics)

Dr. Dina Panagiotopoulos, a pediatric endocrinologist at BC Children’s who was the principal investigator in the study published in the Canadian Journal of Psychiatry, said the increased rates of obesity mean youth face a higher risk of heart disease and cholesterol.

Eli Lilly to pay $24 million in Utah Attorney General’s Zyprexa lawsuit/AG says “we want their bad conduct to stop”

Utah Attorney General Mark Shurtleff sued the company after a nearly four-year investigation revealed that Lilly concealed its knowledge of significant weight gain and obesity associated with the anti-psychotic medication Zyprexa. Investigators also showed that Lilly’s sales representatives illegally promoted the drug for uses not approved by the U.S. Food and Drug Administration.